Above Food Ingredients Inc Warrants
ABVEW
ABVEW was delisted on the 1st of June, 2026.
38 hedge funds and large institutions have $426K invested in Above Food Ingredients Inc Warrants in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 38 → 38 (0)
19% less capital invested
Capital invested by funds: $529K → $426K (-$103K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$488 |
| 2 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$157 |
| 3 |
GS
GTS Securities
Miami,
Florida
|
+$11 |
| 4 |
Jane Street
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$387 |
| 2 |
HF
HRT Financial
New York
|
-$34 |
ABVEW Hedge Fund Activity: Q3 2023 in Review
38 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Above Food Ingredients Inc Warrants (ABVEW) for Q3 2023, worth a combined $426K — down 19% from $529K a quarter earlier.
Fund positioning in ABVEW was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Flow Traders U.S., adding an estimated $488. The largest seller was Citadel Advisors, cutting an estimated $387.
- 38 institutional investors held Above Food Ingredients Inc Warrants (ABVEW) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $426K of Above Food Ingredients Inc Warrants stock for Q3 2023, down 19% quarter-over-quarter.
- 0 funds opened new Above Food Ingredients Inc Warrants positions in Q3 2023 and 0 closed out.
- The largest Above Food Ingredients Inc Warrants buyer in Q3 2023 was Flow Traders U.S., an estimated $488 added.
- The largest Above Food Ingredients Inc Warrants seller in Q3 2023 was Citadel Advisors, an estimated $387 sold.
Based on aggregated 13F filings for Q3 2023.